WVE
Wave Life Sciences (WVE)
$26
About Wave Life Sciences (WVE)
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$21.73
52 Week Low
$5.28
Market cap
2.9B
Dividend yield
0.00%
Volume
--
Avg. volume
13.7M
P/E ratio
-21.55
Wave Life Sciences News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$21.73
52 Week Low
$5.28
Market cap
2.9B
Dividend yield
0.00%
Volume
--
Avg. volume
13.7M
P/E ratio
-21.55